Conventional, molecular methods and biomarkers molecules in detection of septicemia
- PMID: 26261822
- PMCID: PMC4513309
- DOI: 10.4103/2277-9175.158027
Conventional, molecular methods and biomarkers molecules in detection of septicemia
Abstract
Sepsis is a leading cause of morbidity and mortality in hospitalized patients worldwide and based on studies, 30-40% of all cases of severe sepsis and septic shock results from the blood stream infections (BSIs). Identifying of the disease, performing laboratory tests, and consequently treatment are factors that required for optimum management of BSIs. In addition, applying precise and immediate identification of the etiologic agent is a prerequisite for specific antibiotic therapy of pathogen and thereby decreasing mortality rates. The diagnosis of sepsis is difficult because clinical signs of sepsis often overlap with other noninfectious cases of systemic inflammation. BSIs are usually diagnosed by performing a series of techniques such as blood cultures, polymerase chain reaction-based methods, and biomarkers of sepsis. Extremely time-consuming even to take up to several days is a major limitation of conventional methods. In addition, yielding false-negative results due to fastidious and slow-growing microorganisms and also in case of antibiotic pretreated samples are other limitations. In comparison, molecular methods are capable of examining a blood sample obtained from suspicious patient with BSI and gave the all required information to prescribing antimicrobial therapy for detected bacterial or fungal infections immediately. Because of an emergency of sepsis, new methods are being developed. In this review, we discussed about the most important sepsis diagnostic methods and numbered the advantage and disadvantage of the methods in detail.
Keywords: Biomarkers; blood-culture; molecular methods; sepsis.
Conflict of interest statement
References
-
- Von Paula GF. The Hippocrates Zweyten eighth medical writings: Aubersetzt into German: With an alphabetic index of rates and matters; a paperback book for young doctors. Lentner. 1814
-
- Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4:751–60. - PubMed
-
- Riedel S, Carroll KC. Laboratory detection of sepsis: Biomarkers and molecular approaches. Clin Lab Med. 2013;33:413–37. - PubMed
-
- Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis. 2009;48(Suppl 4):S238–45. - PubMed
-
- Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol. 2007;139:519–31. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
